Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. 1988

R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
Department of Surgery, University Health Center of Pittsburgh, University of Pittsburgh, PA.

Experience with the use of Orthoclone OKT3 monoclonal antibody for the treatment of acute cellular rejection in a series of 130 human orthotopic liver transplantations is reviewed. Treatment was highly effective in reversing rejection, in reducing the rate of retransplantation, and in lowering patient mortality. OKT3 was also useful for cyclosporine sparing in patients with poor renal function, hypertension, or CNS toxicity. There was a significant incidence of opportunistic infection associated with the use of OKT3.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
September 1991, Zeitschrift fur Gastroenterologie,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
October 1987, Transplantation proceedings,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
January 1987, Nephron,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
April 1987, Transplantation proceedings,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
August 1986, Transplantation proceedings,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
April 1987, Transplantation proceedings,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
April 1987, Transplantation proceedings,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
September 1988, Annals of surgery,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
June 1989, Der Internist,
R D Gordon, and A G Tzakis, and S Iwatsuki, and S Todo, and C O Esquivel, and J W Marsh, and A Stieber, and L Makowka, and T E Starzl
January 1989, The Journal of heart transplantation,
Copied contents to your clipboard!